BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22547134)

  • 1. Wiskott-Aldrich syndrome with IgA nephropathy: a case report and literature review.
    Liu CH; Wu KH; Lin TY; Wei CC; Lin CY; Chen XX; Lee WI
    Int Urol Nephrol; 2013 Oct; 45(5):1495-500. PubMed ID: 22547134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgA glomerulonephritis in Wiskott-Aldrich syndrome.
    DeSanto NG; Sessa A; Capodicasa G; Meroni M; Capasso G; Esposito L; Ferrara M; Torri Tarelli L; Annunziata S; Giordano C
    Child Nephrol Urol; 1988-1989; 9(1-2):118-20. PubMed ID: 3251617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Henoch-Schönlein purpura with immunoglobulin A nephropathy and abnormalities of immunoglobulin A in a Wiskott-Aldrich syndrome carrier.
    Lasseur C; Allen AC; Deminière C; Aparicio M; Feehally J; Combe C
    Am J Kidney Dis; 1997 Feb; 29(2):285-7. PubMed ID: 9016903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA nephropathy in a patient with polycythemia vera. Clinical manifestation of chronic renal failure and heavy proteinuria.
    Chung J; Park PG; Song KI
    Am J Nephrol; 2002; 22(4):397-401. PubMed ID: 12169877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary spherocytosis with immunoglobulin A nephropathy.
    Biyikli NK; Gokce I; Cakalagaoglu F; Turkkan E; Alpay H
    Iran J Kidney Dis; 2010 Jan; 4(1):78-81. PubMed ID: 20081310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
    Pozzi C; Del Vecchio L; Locatelli F
    G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and outcome of IgA nephropathy in children from one single center experience.
    Mao Y; Zhou W; Zhou Z; Zhang C; Shen J; Yin L
    BMC Pediatr; 2023 Jul; 23(1):377. PubMed ID: 37495962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of crescentic IgA nephropathy after renal transplantation.
    Zagkotsis G; Vourlakou C; Paraskevopoulos A; Apostolou T
    CEN Case Rep; 2018 Nov; 7(2):268-273. PubMed ID: 29802527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membranous nephropathy in a female patient with X-linked thrombocytopenia.
    Okada M; Nagasawa M; Oshiba A; Kawaguchi H
    Pediatr Nephrol; 2023 Aug; 38(8):2873-2876. PubMed ID: 36451038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
    Yagi K; Okada M; Yanagida H; Kuwajima H; Ikeda M; Sugimoto K; Takemura T
    Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin.
    Perico N; Remuzzi A; Sangalli F; Azzollini N; Mister M; Ruggenenti P; Remuzzi G
    J Am Soc Nephrol; 1998 Dec; 9(12):2308-17. PubMed ID: 9848785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Long-term Graft Survival of a Renal Transplantation Patient with Wiskott-Aldrich Syndrome.
    Kai K; Sumida M; Motoyoshi Y; Ogawa Y; Miki K; Iwadoh K; Sannomiya A; Murakami T; Koyama I; Kitajima K; Nakajima I; Morio T; Fuchinoue S
    Intern Med; 2016; 55(13):1761-3. PubMed ID: 27374679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [IgA nephropathy].
    Alamartine E
    Rev Prat; 2003 Nov; 53(18):2023-6. PubMed ID: 15008216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy.
    Tanaka H; Suzuki K; Nakahata T; Tsugawa K; Konno Y; Tsuruga K; Ito E; Waga S
    Pediatr Int; 2004 Oct; 46(5):576-9. PubMed ID: 15491387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial.
    Praga M; Gutiérrez E; González E; Morales E; Hernández E
    J Am Soc Nephrol; 2003 Jun; 14(6):1578-83. PubMed ID: 12761258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathological characteristics of Fabry disease combined with IgA nephropathy in Chinese patients
.
    Yang N; Wang X; Xu F; Zeng C; Wang J; Liu Z
    Clin Nephrol; 2017 Apr; 87 (2017)(4):188-195. PubMed ID: 28157068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexisting Membranous Nephropathy and IgA Nephropathy.
    Nishida M; Kato R; Hamaoka K
    Fetal Pediatr Pathol; 2015; 34(6):351-4. PubMed ID: 26418809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful renal transplantation in a patient with a Wiskott-Aldrich syndrome protein (WASP) gene mutation.
    Chovancova Z; Kuman M; Vlkova M; Litzman J
    Transpl Int; 2015 Aug; 28(8):1005-9. PubMed ID: 25864580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose sirolimus combined with angiotensin-converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy.
    Cruzado JM; Poveda R; Ibernón M; Díaz M; Fulladosa X; Carrera M; Torras J; Bestard O; Navarro I; Ballarín J; Romero R; Grinyó JM
    Nephrol Dial Transplant; 2011 Nov; 26(11):3596-602. PubMed ID: 21393611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy.
    Zhang Q; Shi SF; Zhu L; Lv JC; Liu LJ; Chen YQ; Zhang H; Wang HY
    Am J Nephrol; 2012; 35(4):312-20. PubMed ID: 22456060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.